GLP-1 drugs are shaking things up in the market! Novo Nordisk's Ozempic is a game-changer, showing early signs of helping diabetes patients' kidneys. This news made dialysis providers like DaVita (-17%) and Fresenius Medical (-17.6%) stocks drop big time.
Ironically, these drugs could keep folks on dialysis for longer, creating short-term chances for the providers. Plus, Novo's Ozempic is on fire and could help up to 5 million patients, which is negative for consumer snack companies.
[link] [comments] https://www.reddit.com/r/stocks/comments/175yskf/glp1_drugs_sent_davita_17_lower/
Войдите, чтобы добавить комментарий
Другие сообщения в этой группе
Please use this thread to discuss your portfolio, learn of other stock tickers, and help out users by giving constructive criticism.
Why quarterly? Public comp
When you sell a stock to buy another stock, do you prefer to set the estimated amount of the capital gains taxes aside in a money market or do you think it better to
Saving for retirement is crucial, but relying solely on a 401(k) might not be enough due to high inflation. Consider investing in growth stocks, especially in the tec
I’m think this is not a good investment as there is no chatter at all on the 52 week low. They are involved in a class action lawsuits by investors and credit card co
Sorry if this is the wrong sub. Let’s say I had $1 million in VOO but I wanted to sell half of it to buy SCHD. It would suck to pay taxes on $500k. So how would you g
Hey guys, I did a deep dive into Crocs. In this analysis, I will do a brief breakdown of the company and go over some quantitative data, qualitative data and estimate
